Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$22.17 - $51.8 $3.42 Million - $8 Million
154,355 Added 281.33%
209,221 $10.8 Million
Q2 2022

Aug 15, 2022

SELL
$15.36 - $27.51 $181,770 - $325,553
-11,834 Reduced 17.74%
54,866 $1.36 Million
Q1 2021

May 17, 2021

SELL
$49.53 - $68.4 $416,052 - $574,560
-8,400 Reduced 11.19%
66,700 $3.42 Million
Q4 2020

Feb 03, 2021

SELL
$47.25 - $65.16 $113,400 - $156,384
-2,400 Reduced 3.1%
75,100 $4.65 Million
Q3 2020

Nov 16, 2020

BUY
$46.35 - $61.69 $213,210 - $283,774
4,600 Added 6.31%
77,500 $4.25 Million
Q2 2020

Aug 12, 2020

BUY
$38.58 - $65.07 $385,800 - $650,699
10,000 Added 15.9%
72,900 $4.2 Million
Q1 2020

May 06, 2020

BUY
$32.73 - $50.78 $58,913 - $91,404
1,800 Added 2.95%
62,900 $2.53 Million
Q3 2019

Nov 12, 2019

BUY
$6.47 - $8.96 $196,041 - $271,488
30,300 Added 98.38%
61,100 $414,000
Q2 2019

Aug 14, 2019

BUY
$8.31 - $14.85 $5,817 - $10,395
700 Added 2.33%
30,800 $286,000
Q1 2019

May 13, 2019

BUY
$10.01 - $13.89 $69,069 - $95,841
6,900 Added 29.74%
30,100 $418,000
Q4 2018

Feb 11, 2019

BUY
$9.15 - $12.26 $38,430 - $51,492
4,200 Added 22.11%
23,200 $253,000
Q3 2017

Nov 01, 2017

BUY
$6.5 - $10.69 $123,500 - $203,110
19,000
19,000 $141,000

Others Institutions Holding CCXI

About ChemoCentryx, Inc.


  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.